Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Treasury Shares (2016 - 2025)

Bio-Techne (TECH) has 15 years of Treasury Shares data on record, last reported at $831000.0 in Q2 2025.

  • For Q2 2025, Treasury Shares rose 67.2% year-over-year to $831000.0; the TTM value through Jun 2025 reached $831000.0, up 67.2%, while the annual FY2025 figure was $831000.0, 67.2% up from the prior year.
  • Treasury Shares reached $831000.0 in Q2 2025 per TECH's latest filing, up from $497000.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.4 million in Q4 2023 and bottomed at $66000.0 in Q2 2022.
  • Average Treasury Shares over 5 years is $473500.0, with a median of $369500.0 recorded in 2021.
  • The widest YoY moves for Treasury Shares: up 383.33% in 2022, down 82.72% in 2022.
  • A 5-year view of Treasury Shares shows it stood at $357000.0 in 2021, then plummeted by 37.82% to $222000.0 in 2022, then surged by 529.28% to $1.4 million in 2023, then crashed by 64.42% to $497000.0 in 2024, then surged by 67.2% to $831000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $831000.0 in Q2 2025, $497000.0 in Q2 2024, and $1.4 million in Q4 2023.